Maria Shatz, Ph.D. - Publications

2007 BIR Biological Regulation Weizmann Institute of Science, Rehovot, Israel 
Molecular Biology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Shatz M, Shats I, Menendez D, Resnick MA. p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways. Oncotarget. 6: 16963-80. PMID 26220208 DOI: 10.18632/Oncotarget.4435  0.52
2014 Lowe JM, Menendez D, Bushel PR, Shatz M, Kirk EL, Troester MA, Garantziotis S, Fessler MB, Resnick MA. p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Research. 74: 2182-92. PMID 24737129 DOI: 10.1158/0008-5472.Can-13-1070  0.52
2013 Madenspacher JH, Azzam KM, Gowdy KM, Malcolm KC, Nick JA, Dixon D, Aloor JJ, Draper DW, Guardiola JJ, Shatz M, Menendez D, Lowe J, Lu J, Bushel P, Li L, et al. p53 Integrates host defense and cell fate during bacterial pneumonia. The Journal of Experimental Medicine. 210: 891-904. PMID 23630228 DOI: 10.1084/Jem.20121674  0.52
2013 Menendez D, Shatz M, Resnick MA. Interactions between the tumor suppressor p53 and immune responses. Current Opinion in Oncology. 25: 85-92. PMID 23150340 DOI: 10.1097/Cco.0B013E32835B6386  0.52
2012 Shatz M, Menendez D, Resnick MA. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Research. 72: 3948-57. PMID 22673234 DOI: 10.1158/0008-5472.Can-11-4134  0.52
2011 Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, Resnick MA. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. Plos Genetics. 7: e1001360. PMID 21483755 DOI: 10.1371/Journal.Pgen.1001360  0.52
2010 Shatz M, Lustig G, Reich R, Liscovitch M. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Experimental Cell Research. 316: 1748-62. PMID 20153318 DOI: 10.1016/J.Yexcr.2010.02.006  0.52
2008 Shatz M, Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. International Journal of Radiation Biology. 84: 177-89. PMID 18300018 DOI: 10.1080/09553000701745293  0.52
2007 Burgermeister E, Xing X, Röcken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, Ebert MP. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Research. 67: 8519-26. PMID 17875691 DOI: 10.1158/0008-5472.Can-07-1125  0.52
2007 Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, et al. Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. Cancer Cell. 11: 133-46. PMID 17292825 DOI: 10.1016/J.Ccr.2006.11.022  0.52
2005 Liscovitch M, Burgermeister E, Jain N, Ravid D, Shatz M, Tencer L. Caveolin and cancer: A complex relationship Membrane Microdomain Signaling: Lipid Rafts in Biology and Medicine. 161-190. DOI: 10.1385/1-59259-803-X:161  0.52
2004 Shatz M, Liscovitch M. Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins? Leukemia Research. 28: 907-8. PMID 15234566 DOI: 10.1016/J.Leukres.2004.03.013  0.52
Show low-probability matches.